The Post-marketing Clinical Safety Evaluation of Yiqi Fumai Injection with Hospital Centralized Monitoring

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-17012568

Enrollment

Unknown

Registered

2017-09-04

Start date

2016-05-11

Completion date

Unknown

Last updated

2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not Limited

Interventions

Case series:Yiqi Tongmai (freeze-dried) injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients treated with intravenous injection of Fu mai (freeze-dried) were included in the study, and the study did not limit the patient's characteristics, including age, sex, type of disease, and condition of the disease

Exclusion criteria

Exclusion criteria: Population with a history of hypersensitivity to the injection of the Yiqi Tongmai (freeze-dried)

Design outcomes

Primary

Measure	Time frame
Safety;	—

Countries

China

Contacts

Public ContactCao Hongbo

Tianjin University of Traditional Chinese Medicine

caohb@tice.com.cn+86 13752330880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026